UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 18, 2019

Accession Number:	0001193125-19-262830
Submission Type:	POS AM
CIK: 0001492422 Company Name: Apellis Pharmaceuticals, Inc. File Number: 333-229091